Hualan Biological Engineering
002007.SZ
#2887
Rank
S$6.05 B
Marketcap
$3.31
Share price
2.53%
Change (1 day)
-18.99%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2024 (TTM): S$0.31 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are S$0.69 Billion. In 2023 the company made an earning of S$0.39 Billion, an increase over its 2022 earnings that were of S$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) S$0.31 B-19.57%
2023 S$0.39 B39.21%
2022 S$0.28 B-19.12%
2021 S$0.35 B-17.9%
2020 S$0.42 B37.11%
2019 S$0.31 B11.71%
2018 S$0.28 B50.84%
2017 S$0.18 B1.1%
2016 S$0.18 B23.49%
2015 S$0.14 B8.37%
2014 S$0.13 B10.83%
2013 S$0.12 B54.56%
2012 S$80.29 M-17.03%
2011 S$96.77 M-41.34%
2010 S$0.16 B6.15%
2009 S$0.15 B261.3%
2008 S$43.01 M85.75%
2007 S$23.15 M49.27%
2006 S$15.51 M56.98%
2005 S$9.88 M34.28%
2004 S$7.36 M